Clinical Trial Update: CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating CAR T cell receptor immunotherapy for B-cell lymphomas completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Diffuse Large B-cell Lymphoma Transformed From Follicular Lymphoma
• Mantle Cell Lymphoma
• Mediastinal B-cell Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Primary Mediastinal B-cell Lymphoma, Diffuse, Large B-cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-21